CCTA is safe and effective, and saves time when assessing patients at low- to intermediate-risk of a heart attack.
Coronary CT angiography (CCTA) in the emergency department is safe and effective, and saves time when assessing patients at low- to intermediate-risk of a heart attack, according to a study published online in the New England Journal of Medicine and presented at the American College of Cardiology 61st Annual Scientific Session.
Researchers from the Perelman School of Medicine at the University of Pennsylvania undertook the large, multicenter American College of Radiology Imaging Network (ACRIN) trial to confirm that CCTA was safe to use in patients with suspected heart attacks, allowing ED physicians the confidence to triage low- to intermediate-risk patients according to the scan’s results.
“Prior research, including work by our research team at Penn, established that CCTA can rapidly identify the extent of coronary artery disease, if present, and suggested the safety of CCTA for clinical decision making,” said Harold I. Litt, MD, PhD, chief of cardiovascular imaging in the Department of Radiology at the university.
RELATED: Early CT Angiography Identifies Recurrent Stroke Risk
The study included 908 low- to intermediate-risk patients with chest pain, who were assigned to the CCTA rapid rule-out strategy group, and 462 who were treated traditionally. Patients from both groups whose testing showed heart muscle injury were admitted to the hospital and those with negative tests were discharged. Patients who had negative tests were called 30 days after enrollment for follow up. No deaths within 30 days of discharge were reported among the 640 patients who had negative CCTA results.
“The trial results have significant potential to establish a new standard of care for low- to intermediate-risk patients, dramatically reduce health care utilization and lower medical costs,” said Judd Hollander, MD, co-principal investigator and clinical research director in the Department of Emergency Medicine at the University of Pennsylvania. “In addition to identifying the patients who could safely be discharged, the trial results showed evaluation with CCTA compared with current practice led to fewer patients having cardiac catheterizations that were found to be unnecessary and identified more patients that truly required hospital care.”
There will be more information available from this trial. “The trial’s secondary aims of comparing health care utilization of the two arms and their respective patient outcomes at one-year follow-up will also be important data to report, given the increasing scrutiny of health-care delivery costs,” said Pamela K. Woodard, MD, head of advanced imaging at Washington University School of Medicine and chair of ACRIN’s Cardiovascular Committee.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.